Vol. 3 No. 3 (2025)

Volume 3, Issue 3 focuses on novel therapeutic strategies across oncology, immunology and neurology. It reviews ginsenosides as multi-target agents against hepatocellular carcinoma, exploring their molecular mechanisms and therapeutic prospects. The issue explores CAR-Treg technology as a cutting-edge approach to modulating autoimmune diseases, and examines the mitochondrial interactome in Parkinson's and Huntington's diseases. Finally, retinal degeneration diseases are decoded from molecular pathways to cutting-edge therapies. Together, the four articles reflect the journal's emphasis on translating molecular discoveries into innovative treatments for complex diseases.